Study: True cost of cancer drugs lower than a decade ago

09/13/2009 | Managed Healthcare Executive

When factoring in longevity and quality of life, the cost of cancer drugs is 30% less than it was 10 years ago, according to Cornell University researchers. The study looked at thousands of colon cancer patients and treatments for the disease, including newer drugs like Avastin and Erbitux, which are boosting survival rates.

View Full Article in:

Managed Healthcare Executive

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD